Carbapenem Resistant Enterobacteriaceae (CRE)

In Ireland, the terms carbapenem resistant Enterobacteriaceae (CRE) and carbapenemase producing Enterobacteriaceae (CPE) are often used interchangeably by healthcare workers when referring to a family of bacteria that live in the bowel. CRE/CPE have developed the ability to become resistant to last-resort powerful antimicrobials known as carbapenems, which makes them more challenging to treat if they go on to cause infection.

This antimicrobial resistance problem was first reported in Ireland in 2009 and is increasing in incidence and has been reported as the cause of outbreaks in healthcare settings.

HSE HCAI AMR programme resources are available at: 

Last update: 30 June 2017